Bipartisan Bill Could Increase Prescription Drug Competition and Lower Prices

eAlert 4709c567-abcf-441a-a5a7-55d64034a2ec

<p>Congress is considering bipartisan legislation that could make lower-priced generic drugs available more quickly. In a new post on <em>To the Point</em>, former congressman Henry Waxman and colleagues explain that the CREATES Act, to be included in an upcoming bill to fund the federal government, tackles one of the key drivers of high drug prices — drug manufacturers’ use of anticompetitive tactics to block access to generic drugs. </p><p>The authors say that, along with increasing the availability of generic drugs, the legislation could generate savings to help pay for other necessary federal spending, including funding for community health centers.</p> Read more